round logo Carthera DISCOVER
Our News

Discover our latest press releases, scientific publications and upcoming events, and stay tuned into the dynamic world of Carthera®

logo-carthera Press Releases

Last publication Press

Carthera receives FDA Breakthrough Device Designation for SonoCloud-9 system

June 2022, 22 - Breakthrough Status allows for enhanced interaction with FDA and recognizes SonoCloud® as innovative and promising approach for treatment of recurrent glioblastoma.

Read more
Press

SonoCloud® technology enhances the efficacy of immunotherapiesfor the treatment of brain tumor.

June 9, 2021 - SonoCloud® device can enhance delivery of CAR-T therapies and penetration of checkpoint inhibitors into the brain of preclinical glioma models.

Read more
Press

Launch of a new phase I/IIclinical trial in collaboration with Northwestern University in Chicago

December 16, 2020 - The trial will recruit up to 39 patients with recurrent glioblastoma to test the SonoCloud-9 device in combination with Abraxane®.

Read more
Press

Carthera receive €2M grant and €10.5M equity from the European Innovation Council

September 14, 2020 - Carthera announces that it has been selected by the EIC (European Innovation Council) pilot gas pedal program for the development of its DOMEUS project.

Read more
Press

First patient enrolled in new clinical trial for SonoCloud technology in melanoma

June 8,2020 - The SoniMel study aims to demonstrate safety of using the SonoCloud® technology with checkpoint inhibitors for the treatment of brain metastases from melanoma.

Read more
Press

Strategic collaboration with US-based company Lantheus

December 9, 2019 - Carthera enters into a strategic collaboration agreement with U.S.-based Lantheus to provide microbubbles for use with the SonoCloud device.

Read more
Press

Latest data from the SonoCloud-9 clinical study presented at SNO on November 20-24, 2019

Carthera will present at this conference an update on its on-going work to develop the SonoCloud for treatment of brain tumors.

Read more
Press

Collaboration with KIYATEC in effort to bring personalized medicine to patients stricken by brain cancer

November 18, 2019 - KIYATEC and Carthera announce that they have entered into a clinical collaboration for the purpose of advancing innovation and improving treatments for patients with glioblastoma.

Read more
Press

FDA approval to launch a Phase 1/2a trial in glioblastoma

July 9, 2019 - Carthera receives FDA approval to launch a Phase 1/2a clinical trial in the US with its SonoCloud-9 device in patients with recurrent glioblastoma.

Read more
Press

Pascal Girin, new chairman of the Board of Directors

June 25, 2019 - Carthera appoints Pascal Girin as chairman of Board of Directors

Read more

logo-carthera INTERESTED IN RECEIVING OUR PRESS RELEASES? Join our Distribution List

Please provide us with your mail address

    Social Network

    All our news on LinkedIn
    Follow us

    logo-carthera Scientific Publications

    Last publication Scientific publication

    Pilot study of repeated blood-brain barrier disruption in patients with mild Alzheimer's disease

    Alzheimer’s Research & Therapy - March 2022

    Request for publication
    Scientific publication

    Ultrasound-induced blood-brain barrier disruption for the treatment of gliomas and other primary CNS tumors

    Cancer Letters - June 2020

    Request for publication
    Scientific publication

    Blood–brain barrier opening with low intensity pulsed ultrasound for immune modulation and immune therapeutic delivery to CNS tumors

    Journal of Neuro-Oncology - February 2020

    Request for publication
    Scientific publication

    Ultrasound-mediated Delivery of Paclitaxel for Glioma: A Comparative Study of Distribution, Toxicity, and Efficacy of Albumin-bound Versus Cremophor Formulations

    Clinical Cancer Research - January 2020

    Request for publication
    Scientific publication

    Blood-brain barrier disruption with low-intensity pulsed ultrasound for the treatment of pediatric brain tumors: a review and perspectives

    Neurosurg Focus - January 2020

    Request for publication
    Scientific publication

    Study of the means to characterize the opening of the blood-brain barrier induced by an implantable ultrasound device

    PhD Thesis from Université de Lyon - December 2019

    Request for publication
    Scientific publication

    Temporary blood–brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma

    Journal of Neuro-Oncology - June 2019

    Request for publication
    Scientific publication

    Safety and Feasibility of Repeated and Transient Blood–Brain Barrier Disruption by Pulsed Ultrasound in Patients with Recurrent Glioblastoma

    Clinical Cancer Research - March 2019

    Request for publication
    Scientific publication

    Blood-brain barrier disruption in humans using an implantable ultrasound device: quantification with MR images and correlation with local acoustic pressure

    Journal of NeuroSurgery - February 2019

    Request for publication
    Scientific publication

    Potentialisation des chimiothérapies dans le traitement du glioblastome : étude des transporteurs ABC et ouverture de la barrière hémato-encéphalique par ultrasons

    PhD Thesis from Université Paris-Saclay prepared at Université Paris-Sud - May 2018

    Request for publication

    logo-carthera Agenda Our Events